Investors & News

Investor Relations

Webcast ImageWebcast
Q1 2017 Ascendis Pharma Earnings Conference Call (Replay)
05/23/17 at 4:30 p.m. ET
Q1 2017 Ascendis Pharma Earnings Conference Call
Tuesday, May 23, 2017 4:30 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar

Ascendis Pharma is a clinical stage biopharmaceutical company applying its TransCon technology to develop a pipeline of long-acting prodrug therapies with best-in-class profiles to address large markets with significant unmet medical needs.

Stock Information
ASND (Common Stock)
ExchangeNASDAQ GS (US Dollar)
Price$24.23
Change (%) Stock is Down 0.8 (3.20%)
Volume49,502
Data as of 05/26/17 3:59 p.m. ET
Refresh quote
Stock chart for: ASND.O.  Currently trading at $24.23 with a 52 week high of $31.86 and a 52 week low of $11.92.
Recent NewsMore >>
23/May/2017
Ascendis Pharma A/S Reports First Quarter 2017 Financial Results
11/May/2017
Ascendis Pharma A/S Announces First Quarter 2017 Financial Results Conference Call on May 23
28/Apr/2017
Ascendis Pharma A/S Announces Upcoming Investor Presentations
Upcoming EventsMore >>
There are currently no events scheduled.
Primary IR Contact
Scott T. Smith
Chief Financial Officer
Ascendis Pharma
E-mail: ir@ascendispharma.com

Data provided by Nasdaq. Minimum 15 minutes delayed.